Skip to main content
Clinical Trials/NCT01313247
NCT01313247
Unknown
Phase 4

Optimizing Medication for Cancer Pain. The Effect of Paracetamol. A Clinical and Pharmacological Trial to Research Whether Paracetamol Gives an Additional Effect on Pain Relief When the Patient is Treated With High Doses of Opioids

Haraldsplass Deaconess Hospital1 site in 1 country50 target enrollmentApril 2011

Overview

Phase
Phase 4
Intervention
placebo tablets
Conditions
Advanced Cancer
Sponsor
Haraldsplass Deaconess Hospital
Enrollment
50
Locations
1
Primary Endpoint
Pain reduction caused by paracetamol 4g/d
Last Updated
15 years ago

Overview

Brief Summary

Randomised, double-blind placebo controlled cross-over trial

Main goal:

Optimize the medical pain treatment for patients with advanced cancer disease

Study goal:

Measure paracetamol's additional analgesic effect in a situation where the patient is concomitantly treated with oral opioids eqv. morphine > 100 mg/d.

Detailed Description

National multicenter study with an intention to include 50 patients. 6 days treatment, 3d in each arm. Mean pain score last 24 h: NRS =/\> 4 All drug treatment constant during the study period. The participants are allowed to take as much rescue opioids as necessary to have adequate relief. Paracetamol/ placebo given orally 1000 mg x 4 daily, three days in each arm, direct crossover. Daily scoring of pain relief, ESAS, overall satisfaction and rescue medication.

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
December 2012
Last Updated
15 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Haraldsplass Deaconess Hospital

Eligibility Criteria

Inclusion Criteria

  • Adults (\> 18 years) of both sexes
  • Diagnosed with advanced cancer disease
  • Ongoing medicinal pain relief treatment in stable dosing with oral opiates equivalent to \> 100 mg oral morphine daily
  • NRS median pain score last 24 hrs \> 4
  • Able to take tablets (paracetamol) orally

Exclusion Criteria

  • Mental or physical deficiency precluding data collection.
  • Reduced liver function judged with bilirubin, INR and transaminases
  • Anticoagulation with warfarin
  • Ongoing use of NSAIDs or 5-HT3 antagonists, or use of such drugs last week
  • Ongoing palliative radiation treatment or radiation treatment during the last 4 weeks.

Arms & Interventions

Placebo pills

Placebo tablets resembling paracetamol 500 mg are given as alternative 2 tablets 4 times daily

Intervention: placebo tablets

oral paracetamol 4 g daily

Patients are given 2 tablets of 500 mg paracetamol on a regular basis 4 times daily

Intervention: paracetamol

Outcomes

Primary Outcomes

Pain reduction caused by paracetamol 4g/d

Time Frame: Last day in each 3 days study period

Pain reduction in the active paracetamol arm, compared to placebo, corrected for difference in rescue medication intake.

Secondary Outcomes

  • Overall satisfaction with the pain treatment(End of each 3 days study period)

Study Sites (1)

Loading locations...

Similar Trials